Abstract
Using in vivo models of pancreatic ductal adenocarcinoma (PDAC), we demonstrated that mast cells migrate to the tumor site and provide a microenvironment that allows for tumor progression. These results indicate that targeting mast cells may be a promising novel therapy for PDAC. ©2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Chang, D. Z. (2012). Mast cells in pancreatic ductal adenocarcinoma. OncoImmunology, 1(5), 754–755. https://doi.org/10.4161/onci.19612
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free